表紙
市場調查報告書

全球睡眠呼吸中止症市場規模,佔有率,趨勢分析:各產品(治療(PAP,口服,經鼻,下巴),診斷(呼吸多導生理記錄儀,活動記錄器,睡眠多頻道記錄,脈動式血氧監測儀系統),各地區(2019∼2025年)

Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product Type (Therapeutic, Diagnostic), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 906553
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
全球睡眠呼吸中止症市場規模,佔有率,趨勢分析:各產品(治療(PAP,口服,經鼻,下巴),診斷(呼吸多導生理記錄儀,活動記錄器,睡眠多頻道記錄,脈動式血氧監測儀系統),各地區(2019∼2025年) Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product Type (Therapeutic, Diagnostic), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2020 - 2027
出版日期: 2020年03月12日內容資訊: 英文 100 Pages
簡介

全球睡眠呼吸中止症市場規模預測今後將以年複合成長率6.8%擴大,至2025年達到126億1,000萬美元的規模。患睡眠呼吸中止症病的患者數增加,意識的提高,治療率的上升市場收益擴大有所貢獻。

本報告提供全球睡眠呼吸中止症市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊彙整。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
  • 市場趨勢
    • 推動市場的要素分析
    • 阻礙市場的要素分析
    • 滲透及成長預測製圖
    • 產業分析
    • PESTEL分析
    • 患者群
    • 產品引進分析
    • 供應鏈分析
    • 案例研究

第4章 各產品預測、趨勢分析

  • 市場概要
  • 市場佔有率分析
    • 治療設備
    • 診斷設備
  • 治療設備
    • 口服設備
    • 經鼻設備
    • 經下巴設備
  • 診斷設備
    • 呼吸多導生理記錄儀
    • 活動記錄器
    • 睡眠多頻道記錄
    • 脈動式血氧監測儀系統

第5章 各地區市場分析

  • 市場概要
  • 市場佔有率和主要企業
  • SWOT分析
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場規模與預測,趨勢分析

第6章 競爭環境

  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-265-5

The global sleep apnea devices market size is projected to reach USD 10.3 billion by 2027, expanding at a CAGR of 7.4% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from obstructive sleep apnea (OSA) is a key factor expected to drive the market growth. Furthermore, growing awareness about the condition and related comorbidities is likely to drive the growth over the forecast period. However, high cost of diagnosis and treatment for sleeping disorders is one of the key factors anticipated to restrain the market growth.

Based on product type, the market is segmented into diagnostic and therapeutic devices. In 2019, the therapeutic devices segment dominated the market with a revenue share of 64.1%. The penetration of these devices has grown at a lucrative rate over the past few years, owing to promising reimbursement guidelines in various countries. Moreover, availability of technologically advanced and innovative products has enhanced the growth of this segment. On the other hand, the diagnostic device segment is expected to grow at the fastest rate over the forecast period, owing to a rise in the number of patients diagnosed with respiratory disorders.

Based on region, North America dominated the market in 2019 with a revenue share of 51.5%. Presence of major market participants and rising awareness related to sleeping disorders and associated diseases in the region has reinforced the sleep apnea devices industry growth in the region. On the other hand, the Asia Pacific region is expected to grow at the fastest CAGR over the forecast period, owing to rising prevalence of geriatric population suffering from sleep disorders and establishment of sleep laboratory facilities for testing sleep apnea patients.

Further key findings from the report suggest:

The therapeutic devices segment accounted for a major revenue share of 64.1% in 2019 owing to the availability of technologically advanced products

The diagnostic devices segment is expected to witness a lucrative growth rate of 7.6% owing to increasing number of patients diagnosed with respiratory disorders and rising awareness regarding the disease

North America dominated the market in 2019, owing to increasing awareness related to obstructive sleep apnea (OSA) and associated comorbidities in the region

Some of the key players in the sleep apnea devicesmarket are Curative Medical Inc.; Philips Respironics; ResMed; Fisher & Paykel Healthcare; Cadwell Laboratories; and Invacare Corporation.

Table Of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
  • 1.2 Research Methodology
    • 1.2.1 Information Procurement
  • 1.3 Information or Data Analysis
  • 1.4 Market Formulation & Validation
    • 1.4.1 Region Market: CAGR Calculation
  • 1.5 Region Based Segment Share Calculation
  • 1.6 List Of Secondary Sources
  • 1.7 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot, Revenue (USD Million)

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Penetration & Growth Prospect Mapping
  • 3.2 Sleep Apnea Devices Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraints Analysis
    • 3.2.3 Industry Challenge
  • 3.3 Sleep Apnea Devices Market Analysis Tools
      • 3.3.1.Industry Analysis - Porter's
      • 3.3.1.1.Supplier Power
      • 3.3.1.2.Buyer Power
      • 3.3.1.3.Substitution Threat
      • 3.3.1.4.Threat From New Entrant
      • 3.3.1.5.Competitive Rivalry
      • 3.3.2.PESTEL Analysis
      • 3.3.2.1.Political Landscape
      • 3.3.2.2.Environmental Landscape
      • 3.3.2.3.Social Landscape
      • 3.3.2.4.Technology Landscape
      • 3.3.2.5.Legal Landscape
  • 3.4 Regulatory Framework
      • 3.4.1.Compliance Standards of PAP Devices for Key Countries
      • 3.4.1.1.Manufacturing Compliances
      • 3.4.1.2.Payer Compliances
      • 3.4.1.3.Patient Compliances
  • 3.5 Prevalence Of Obstructive Sleep Apnea (OSA) By Country, 2016 - 2027
  • 3.6 Incidence Of Obstructive Sleep Apnea (OSA) By Country, 2016 - 2027
  • 3.7 Product Pipeline Analysis

Chapter 4 Sleep Apnea Devices Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company Market Position Analysis
  • 4.3 Company Market Share Analysis, 2019
  • 4.4 Market Differentiators
  • 4.5 List of Key Emerging Companies

Chapter 5 Sleep Apnea Devices Market: Product Type Market Estimates & Trend Analysis

  • 5.1. Product Type Market Movement Analysis & Market Share, 2019 & 2027
  • 5.2. Market Revenue Size & Forecasts and Trend Analysis, 2016 to 2027 for the Following Product Types:
      • 5.2.1.Diagnostic Devices
      • 5.2.1.1. Actigraphs
      • 5.2.1.2. Polysomnography (PSG) Device
      • 5.2.1.3. Respiratory Polygraphs
      • 5.2.1.4. Pulse Oximeters
    • 5.2.2. Therapeutic Devices
      • 5.2.2.1. Positive Airway Pressure (PAP) Devices
      • 5.2.2.1.1. CPAP
      • 5.2.2.1.2. APAP
      • 5.2.2.1.3. Bi-PAP
      • 5.2.2.2. Oral Devices
      • 5.2.2.3. Nasal Devices
      • 5.2.2.4. Chin Straps

Chapter 6 Sleep Apnea Devices Market: Regional Estimates & Trend Analysis by Product Type

  • 6.1. Regional Market Snapshot (Market Size, CAGR, Key Players, Key Trends)
  • 6.2. Market Size & Forecasts, and Trend Analysis, 2019 to 2027
    • 6.2.1. North America
      • 6.2.1.1. U.S.
      • 6.2.1.2. Canada
    • 6.2.2. Europe
      • 6.2.2.1. U.K.
      • 6.2.2.2. Germany
      • 6.2.2.3. Spain
      • 6.2.2.4. France
      • 6.2.2.5. Italy
      • 6.2.2.6. Russia
    • 6.2.3. Asia Pacific
      • 6.2.3.1. China
      • 6.2.3.2. Japan
      • 6.2.3.3. India
      • 6.2.3.4. South Korea
      • 6.2.3.5. Singapore
      • 6.2.3.6. Australia
    • 6.2.4. Latin America
      • 6.2.4.1. Brazil
      • 6.2.4.2. Argentina
      • 6.2.4.3. Mexico
    • 6.2.5. Middle East & Africa (MEA)
      • 6.2.5.1. South Africa
      • 6.2.5.2. Saudi Arabia
      • 6.2.5.3. UAE

Chapter 7 Competitive Landscape

  • 7.1. Company Profiles
    • 7.1.1. BMC Medical Co. Ltd.
      • 7.1.1.1. Company overview
      • 7.1.1.2. Financial Performance
      • 7.1.1.3. Product benchmarking
      • 7.1.1.4. Strategic Initiatives
    • 7.1.2. Braebon Medical Corporation
      • 7.1.2.1. Company overview
      • 7.1.2.2. Financial Performance
      • 7.1.2.3. Product benchmarking
      • 7.1.2.4. Strategic Initiatives
    • 7.1.3. Carefusion Corp
      • 7.1.3.1. Company overview
      • 7.1.3.2. Financial Performance
      • 7.1.3.3. Product benchmarking
      • 7.1.3.4. Strategic Initiatives
    • 7.1.4. Compumedics Limited
      • 7.1.4.1. Company overview
      • 7.1.4.2. Financial Performance
      • 7.1.4.3. Product benchmarking
      • 7.1.4.4. Strategic Initiatives
    • 7.1.5. Curative Medical Inc.
      • 7.1.5.1. Company overview
      • 7.1.5.2. Financial Performance
      • 7.1.5.3. Product benchmarking
      • 7.1.5.4. Strategic Initiatives
    • 7.1.6. Fisher & Paykel Healthcare
      • 7.1.6.1. Company overview
      • 7.1.6.2. Financial Performance
      • 7.1.6.3. Product benchmarking
      • 7.1.6.4. Strategic Initiatives
    • 7.1.7. GE Healthcare
      • 7.1.7.1. Company overview
      • 7.1.7.2. Financial Performance
      • 7.1.7.3. Product benchmarking
      • 7.1.7.4. Strategic Initiatives
    • 7.1.8. ImThera Medical Inc.
      • 7.1.8.1. Company overview
      • 7.1.8.2. Financial Performance
      • 7.1.8.3. Product benchmarking
      • 7.1.8.4. Strategic Initiatives
    • 7.1.9. Invacare Corporation
      • 7.1.9.1. Company overview
      • 7.1.9.2. Financial Performance
      • 7.1.9.3. Product benchmarking
      • 7.1.9.4.Strategic Initiatives
    • 7.1.10. Itamar Medical Ltd.
      • 7.1.10.1.Company overview
      • 7.1.10.2.Financial Performance
      • 7.1.10.3.Product benchmarking
      • 7.1.10.4.Strategic Initiatives
    • 7.1.11. Natus Medical Inc.
      • 7.1.11.1. Company overview
      • 7.1.11.2. Financial Performance
      • 7.1.11.3. Product benchmarking
      • 7.1.11.4. Strategic Initiatives
    • 7.1.12. Nihon Kohden
      • 7.1.12.1. Company overview
      • 7.1.12.2. Financial Performance
      • 7.1.12.3. Product benchmarking
      • 7.1.12.4. Strategic Initiatives
    • 7.1.13. Philips Respironics
      • 7.1.13.1. Company overview
      • 7.1.13.2. Financial Performance
      • 7.1.13.3. Product benchmarking
      • 7.1.13.4. Strategic Initiatives
    • 7.1.14. ResMed Inc.
      • 7.1.14.1. Company overview
      • 7.1.14.2. Financial Performance
      • 7.1.14.3. Product benchmarking
      • 7.1.14.4. Strategic Initiatives
    • 7.1.15. Somnetics International Inc.
      • 7.1.15.1. Company overview
      • 7.1.15.2. Financial Performance
      • 7.1.15.3. Product benchmarking
      • 7.1.15.4. Strategic Initiatives
    • 7.1.16. SOMNOmedics GmbH
      • 7.1.16.1. Company overview
      • 7.1.16.2. Financial Performance
      • 7.1.16.3. Product benchmarking
      • 7.1.16.4. Strategic Initiatives
    • 7.1.17. Teleflex Inc.
      • 7.1.17.1. Company overview
      • 7.1.17.2. Financial Performance
      • 7.1.17.3. Product benchmarking
      • 7.1.17.4. Strategic Initiatives
    • 7.1.18. Weinmann Medical Devices GmbH & Co. KG.
      • 7.1.18.1. Company overview
      • 7.1.18.2. Financial Performance
      • 7.1.18.3. Product benchmarking
      • 7.1.18.4. Strategic Initiatives

List of Tables

  • Table 1 Product pipeline analysis, by stage
  • Table 2 List of key emerging companies/technology disruptors/innovators
  • Table 3 Sleep apnea devices market, by type 2016 - 2027 (USD Million)
  • Table 4 North America sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 5 U.S. sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 6 Canada sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 7 Europe sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 8 U.K. sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 9 Germany sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 10 Spain sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 11 France sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 12 Italy sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 13 Russia sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 14 Asia Pacific sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 15 Japan sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 16 China sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 17 India sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 18 South Korea sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 19 Singapore sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 20 Australia sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 21 Latin America sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 22 Brazil sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 23 Mexico sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 24 Argentina sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 25 MEA sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 26 Tunisia sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 27 Egypt sleep apnea devices market, by Product type 2016 - 2027 (USD Million)
  • Table 28 South Africa sleep apnea devices market, by Product type 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Sleep apnea devices market variables, trends & scope
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Key company market share analysis, 2019
  • Fig. 14 Market Differentiators
  • Fig. 15 Segment Dashboard
  • Fig. 16 Sleep apnea devices market share: Product movement analysis, 2019 & 2027 (USD Million)
  • Fig. 17 Therapeutic devices market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 18 Sleep Apnea Devices Market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 19 Oral devices market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 20 Nasal devices market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 21 Chin straps market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 22 Diagnosis devices market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 23 Actigraphs market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 24 Polysomnography market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 25 Respiratory polygraphs market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 26 Pulse oximeters market revenue estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 27 Regional market snapshot
  • Fig. 28 Regional outlook, 2019 & 2027
  • Fig. 29 North America sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 30 U.S. sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 31 Canada sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 32 Europe sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 33 Germany sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 34 U.K. sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 35 Spain sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 36 France sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 37 Italy sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 38 Russia sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 39 Asia Pacific sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 40 Japan sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 41 China sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 42 India sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 43 South Korea sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 44 Singapore sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 45 Australia sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 46 Latin America sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 47 Brazil sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 48 Mexico sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 49 Argentina sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 50 MEA sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 51 Tunisia sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 52 Egypt sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)
  • Fig. 53 South Africa sleep apnea devices market estimates and forecasts, 2016 - 2027 (USD Million)